NICE technology appraisal guidance
Issued: May 2011
TA223

Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

View the summary and implementation tools

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta223

7 Related NICE guidance

Published

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of NICE technology appraisal guidance 90). NICE technology appraisal guidance 210 (2010).

Under development

NICE is developing the following guidance (details available from the NICE website):

  • Lower limb peripheral arterial disease. NICE clinical guideline. Publication expected October 2012.